|
Apr 27
|
Medicure Full Year 2024 Earnings: CA$0.10 loss per share (vs CA$0.088 loss in FY 2023)
|
|
Apr 25
|
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024
|
|
Mar 11
|
Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy
|
|
Jun 24
|
Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
|
|
Dec 5
|
Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes
|